Success Stories: We Helped a Graduate Student Researcher from China in the Field of Pharmaceutical Chemistry Achieve NIW Approval Without Any RFE
Client’s Testimonial:
“Thanks for sharing this great news with me! It's been a great experience.”
On January 8th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Student Researcher in the Field of Pharmaceutical Chemistry (Approval Notice).
General Field: Pharmaceutical Chemistry
Position at the Time of Case Filing: Graduate Student Researcher
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: January 8th, 2025
Processing Time: 14 months, 6 days
Case Summary:
With a B.S. in pharmacological chemistry and fundamental research experience, undoubtedly, our client possesses the ability to advance in the same field. When he contacted our law firm to file an I-140 NIW (National Interest Waiver) petition on his behalf, we examined more into his degrees and diplomas, and after thoroughly evaluating his credentials, we established that we would lead him to NIW success and countersigned the retainer agreement.
We intended to prove that he is an essential researcher in his field of expertise therefore we added essential attributes to his NIW (National Interest Waiver) petition packet. We noted that:
- His work has been cited 362 times by dependent and independent researchers, demonstrating that his publications are widely recognized and relied upon in his chosen field.
- We also detailed his contributions to peer-reviewed conference articles which resulted in 3 peer-reviewed journal articles and 1 peer-reviewed conference article.
- His research has been supported with funding from the National Institutes of Health (NIH) and the National Science Foundation (NSF). This funding is reserved solely for research directed at advancing the national interest, including fostering creative discoveries and research strategies to improve public health and prevent disease, and promote and advance science for the benefit of the United States' health, prosperity, and national defense, respectively.
Additionally, his work on computational techniques for accelerated drug discovery has advanced the field and the work of his peers by developing, a computational technique for drug discovery with significant advantages over conventional approaches. Consequently, this work represents progress toward his larger goal of advancing the development of advanced computational techniques for accelerated drug discovery.
Thus, he has provided independent researchers from around the world with useful approaches to the study of complex topics within the field of pharmaceutical chemistry. That other researchers consistently look to his methods and findings to inform and guide their studies indicates that he is well-positioned to make further useful discoveries in the field of pharmaceutical chemistry.
We are pleased that our efforts and hard work, in this case, paid off well in proving that our client’s major contributions in his field of expertise make him an invaluable asset to the United States, thus, he received his NIW (National Interest Waiver) approval. Therefore, we thank him for choosing the North America Immigration Law Group to represent his case and wish him very well as he continues to advance in his proposed field.